Genomics

Genomics company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalised estimates of risk for all the common diseases and cancers, well ahead of disease manifestation, allowing accurate and early interventions and tailored screening. Our proprietary algorithms and databases offer something no competitor can: the ability to accurately link minute variation across the entire genome to changes in thousands of biological measurements and disease outcomes, to generate population-level insights for healthcare systems, individual-level insights for clinicians about the risk of common diseases, and new understanding of disease processes. In August 2018, we announced a multi-year collaboration with Vertex to use human genetics and data science to advance discovery of precision medicines. We also have several pilot programmes in development within UK and US healthcare systems. Our team is a multi-disciplinary group focused on finding powerful and creative solutions for bringing subject-leading science to as wide an audience as possible, and, in doing so, offer the chance of transforming lives around the world. The workforce is highly qualified and consists of over 150 people, including genomic scientists, computational biologists, statisticians, software engineers, product developers, data scientists and commercial strategists. We are headquartered in Oxford, with offices in Cambridge (UK), London (UK), and North Carolina and Framingham (US).

Company Details

Employees
184
Founded
-
Address
King Charles House, Park End Street,united Kingdom
Phone
+44 (0) 1865 981 600
Email
in****@****plc.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Oxford, Oxfordshire
Looking for a particular Genomics employee's phone or email?

Genomics Questions

News

Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association - American Heart Association Journals

Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association American Heart Association Journals

Genomics plc Announces David Thornton as President - PR Newswire

Genomics plc Announces David Thornton as President PR Newswire

Performance of polygenic risk scores in screening, prediction, and risk stratification - medRxiv

Performance of polygenic risk scores in screening, prediction, and risk stratification medRxiv

Genomics plc and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design - PR Newswire

Genomics plc and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design PR Newswire

Realistic expectations are key to realising the benefits of polygenic scores - The BMJ

Realistic expectations are key to realising the benefits of polygenic scores The BMJ

Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction - American Heart Association Journals

Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction American Heart Association Journals

UK Biobank release and systematic evaluation of optimised polygenic risk scores for 53 diseases and quantitative traits - medRxiv

UK Biobank release and systematic evaluation of optimised polygenic risk scores for 53 diseases and quantitative traits medRxiv

Genomics plc Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex - PR Newswire

Genomics plc Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex PR Newswire

Genomics plc and MassMutual's program enables more policyowners to understand health risks through innovative genetic testing - PR Newswire

Genomics plc and MassMutual's program enables more policyowners to understand health risks through innovative genetic testing PR Newswire

An integrated polygenic and clinical risk tool enhances coronary artery disease prediction - medRxiv

An integrated polygenic and clinical risk tool enhances coronary artery disease prediction medRxiv

Top Genomics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant